{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T10:24:50Z","timestamp":1790677490713,"version":"4.1.0"},"reference-count":46,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100006407","name":"Natural Science Foundation of Henan Province","doi-asserted-by":"publisher","award":["242300421506"],"award-info":[{"award-number":["242300421506"]}],"id":[{"id":"10.13039\/501100006407","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006407","name":"Natural Science Foundation of Henan Province","doi-asserted-by":"publisher","award":["242300421506"],"award-info":[{"award-number":["242300421506"]}],"id":[{"id":"10.13039\/501100006407","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Curr. Treat. Options in Oncol."],"published-print":{"date-parts":[[2024,10]]},"DOI":"10.1007\/s11864-024-01265-6","type":"journal-article","created":{"date-parts":[[2024,10,2]],"date-time":"2024-10-02T08:02:12Z","timestamp":1727856132000},"page":"1283-1288","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["The Role of SIRT1 in Leukemia"],"prefix":"10.1007","volume":"25","author":[{"given":"Zhongqi","family":"Wu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5466-6631","authenticated-orcid":false,"given":"Tianxin","family":"Lyu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leizhen","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenqiang","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,10,2]]},"reference":[{"issue":"19","key":"1265_CR1","doi-asserted-by":"publisher","first-page":"14470","DOI":"10.3390\/ijms241914470","volume":"24","author":"GR Fajardo-Ordu\u00f1a","year":"2023","unstructured":"Fajardo-Ordu\u00f1a GR, et al. Role of SIRT1 in chemoresistant leukemia. Int J Mol Sci. 2023;24(19):14470. https:\/\/doi.org\/10.3390\/ijms241914470.","journal-title":"Int J Mol Sci"},{"issue":"12","key":"1265_CR2","doi-asserted-by":"publisher","first-page":"1136","DOI":"10.1056\/NEJMra1406184","volume":"373","author":"H D\u00f6hner","year":"2015","unstructured":"D\u00f6hner H, et al. Acute myeloid leukemia. N Engl J Med. 2015;373(12):1136\u201352. https:\/\/doi.org\/10.1056\/NEJMra1406184.","journal-title":"N Engl J Med"},{"issue":"1","key":"1265_CR3","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1158\/2643-3230.BCD-22-0098","volume":"4","author":"O Lancho","year":"2023","unstructured":"Lancho O, et al. A therapeutically targetable NOTCH1\u2013SIRT1\u2013KAT7 axis in T-cell leukemia. Blood Cancer Discov. 2023;4(1):12\u201333. https:\/\/doi.org\/10.1158\/2643-3230.BCD-22-0098.","journal-title":"Blood Cancer Discov"},{"issue":"5","key":"1265_CR4","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1080\/14728222.2020.1743268","volume":"24","author":"V Vachharajani","year":"2020","unstructured":"Vachharajani V, McCall CE. Sirtuins: potential therapeutic targets for regulating acute inflammatory response? Expert Opin Ther Targets. 2020;24(5):489\u201397. https:\/\/doi.org\/10.1080\/14728222.2020.1743268.","journal-title":"Expert Opin Ther Targets"},{"issue":"15","key":"1265_CR5","doi-asserted-by":"publisher","first-page":"4780","DOI":"10.1021\/acs.jcim.3c00556","volume":"63","author":"H Cai","year":"2023","unstructured":"Cai H, et al. Discovery of novel SIRT1\/2 inhibitors with effective cytotoxicity against human leukemia cells. J Chem Inf Model. 2023;63(15):4780\u201390. https:\/\/doi.org\/10.1021\/acs.jcim.3c00556.","journal-title":"J Chem Inf Model"},{"issue":"2","key":"1265_CR6","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1016\/j.molcel.2007.08.030","volume":"28","author":"E-J Kim","year":"2007","unstructured":"Kim E-J, et al. Active regulator of SIRT1 cooperates with SIRT1 and facilitates suppression of p53 activity. Mol Cell. 2007;28(2):277\u201390. https:\/\/doi.org\/10.1016\/j.molcel.2007.08.030.","journal-title":"Mol Cell"},{"key":"1265_CR7","doi-asserted-by":"publisher","unstructured":"Carafa V, et al. Sirtuin functions and modulation: from chemistry to the clinic. Clin Epigenetics. 2016;8(1). https:\/\/doi.org\/10.1186\/s13148-016-0224-3.","DOI":"10.1186\/s13148-016-0224-3"},{"key":"1265_CR8","doi-asserted-by":"publisher","first-page":"109492","DOI":"10.1016\/j.cellsig.2019.109492","volume":"66","author":"M Heshmati","year":"2020","unstructured":"Heshmati M, et al. Ghrelin induces autophagy and CXCR4 expression via the SIRT1\/AMPK axis in lymphoblastic leukemia cell lines. Cell Signal. 2020;66:109492. https:\/\/doi.org\/10.1016\/j.cellsig.2019.109492.","journal-title":"Cell Signal"},{"issue":"4","key":"1265_CR9","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1097\/MOH.0000000000000152","volume":"22","author":"L Li","year":"2015","unstructured":"Li L, Bhatia R. Role of SIRT1 in the growth and regulation of normal hematopoietic and leukemia stem cells. Curr Opin Hematol. 2015;22(4):324\u20139. https:\/\/doi.org\/10.1097\/MOH.0000000000000152.","journal-title":"Curr Opin Hematol"},{"issue":"4","key":"1265_CR10","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1016\/j.stem.2014.08.001","volume":"15","author":"L Li","year":"2014","unstructured":"Li L, et al. SIRT1 activation by a c-MYC oncogenic network promotes the maintenance and drug resistance of human FLT3-ITD acute myeloid leukemia stem cells. Cell Stem Cell. 2014;15(4):431\u201346. https:\/\/doi.org\/10.1016\/j.stem.2014.08.001.","journal-title":"Cell Stem Cell"},{"issue":"5","key":"1265_CR11","doi-asserted-by":"publisher","first-page":"2091","DOI":"10.7150\/ijbs.63876","volume":"18","author":"J Li","year":"2022","unstructured":"Li J, et al. Specific overexpression of SIRT1 in mesenchymal stem cells rescues hematopoiesis niche in BMI1 knockout mice through promoting CXCL12 expression. Int J Biol Sci. 2022;18(5):2091\u2013103. https:\/\/doi.org\/10.7150\/ijbs.63876.","journal-title":"Int J Biol Sci"},{"key":"1265_CR12","doi-asserted-by":"publisher","unstructured":"Wang F, et al. SIRT1 regulates the phosphorylation and degradation of P27 by deacetylating CDK2 to promote T-cell acute lymphoblastic leukemia progression. J Exp Clin Cancer Res. 2021;40(1). https:\/\/doi.org\/10.1186\/s13046-021-02071-w.","DOI":"10.1186\/s13046-021-02071-w"},{"key":"1265_CR13","doi-asserted-by":"publisher","unstructured":"Tang Y-L, et al. Ginsenoside Rg1 Inhibits Cell Proliferation and Induces Markers of Cell Senescence in CD34+CD38\u2013 Leukemia Stem Cells Derived from KG1\u03b1 Acute Myeloid Leukemia Cells by Activating the Sirtuin 1 (SIRT1)\/Tuberous Sclerosis Complex 2 (TSC2) Signaling Pathway. Med Sci Monit. 2020;26. https:\/\/doi.org\/10.12659\/MSM.918207.","DOI":"10.12659\/MSM.918207"},{"issue":"12","key":"1265_CR14","doi-asserted-by":"publisher","first-page":"3437","DOI":"10.1002\/stem.2218","volume":"33","author":"Z Wang","year":"2015","unstructured":"Wang Z, Chen C-C, Chen W. CD150\u2212 Side Population Defines Leukemia Stem Cells in a BALB\/c Mouse Model of CML and Is Depleted by Genetic Loss of SIRT1. Stem Cells. 2015;33(12):3437\u201351. https:\/\/doi.org\/10.1002\/stem.2218.","journal-title":"Stem Cells"},{"key":"1265_CR15","doi-asserted-by":"publisher","unstructured":"Liu W, et al. ACSL1 promotes imatinib-induced chronic myeloid leukemia cell senescence by regulating SIRT1\/p53\/p21 pathway. Sci Rep. 2022;12(1). https:\/\/doi.org\/10.1038\/s41598-022-21009-6.","DOI":"10.1038\/s41598-022-21009-6"},{"key":"1265_CR16","doi-asserted-by":"publisher","unstructured":"Wang Z, et al. Loss of SIRT1 inhibits hematopoietic stem cell aging and age-dependent mixed phenotype acute leukemia. Commun Biol. 2022;5(1). https:\/\/doi.org\/10.1038\/s42003-022-03340-w.","DOI":"10.1038\/s42003-022-03340-w"},{"issue":"10","key":"1265_CR17","doi-asserted-by":"publisher","first-page":"1234","DOI":"10.1038\/nm.4399","volume":"23","author":"EM Kuntz","year":"2017","unstructured":"Kuntz EM, et al. Targeting mitochondrial oxidative phosphorylation eradicates therapy-resistant chronic myeloid leukemia stem cells. Nat Med. 2017;23(10):1234\u201340. https:\/\/doi.org\/10.1038\/nm.4399.","journal-title":"Nat Med"},{"issue":"7","key":"1265_CR18","doi-asserted-by":"publisher","first-page":"2685","DOI":"10.1172\/JCI127080","volume":"129","author":"A Abraham","year":"2019","unstructured":"Abraham A, et al. SIRT1 regulates metabolism and leukemogenic potential in CML stem cells. J Clin Investig. 2019;129(7):2685\u2013701. https:\/\/doi.org\/10.1172\/JCI127080.","journal-title":"J Clin Investig"},{"key":"1265_CR19","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.canlet.2018.03.024","volume":"425","author":"X Hu","year":"2018","unstructured":"Hu X, et al. CXCR4-mediated signaling regulates autophagy and influences acute myeloid leukemia cell survival and drug resistance. Cancer Lett. 2018;425:1\u201312. https:\/\/doi.org\/10.1016\/j.canlet.2018.03.024.","journal-title":"Cancer Lett"},{"issue":"3","key":"1265_CR20","doi-asserted-by":"publisher","first-page":"456","DOI":"10.1016\/j.molcel.2014.12.013","volume":"57","author":"R Huang","year":"2015","unstructured":"Huang R, et al. Deacetylation of nuclear LC3 drives autophagy initiation under starvation. Mol Cell. 2015;57(3):456\u201366. https:\/\/doi.org\/10.1016\/j.molcel.2014.12.013.","journal-title":"Mol Cell"},{"key":"1265_CR21","doi-asserted-by":"publisher","unstructured":"Huang H, et al. Chidamide enhances the cytotoxicity of cytarabine and sorafenib in acute myeloid leukemia cells by modulating H3K9me3 and autophagy levels. Front Oncol. 2019;9. https:\/\/doi.org\/10.3389\/fonc.2019.01276.","DOI":"10.3389\/fonc.2019.01276"},{"issue":"2","key":"1265_CR22","doi-asserted-by":"publisher","first-page":"543","DOI":"10.3892\/or.2020.7627","volume":"44","author":"A Dong","year":"2020","unstructured":"Dong A, et al. Bioinformatics analysis of the network of histone H3 lysine 9 trimethylation in acute myeloid leukaemia. Oncol Rep. 2020;44(2):543\u201354. https:\/\/doi.org\/10.3892\/or.2020.7627.","journal-title":"Oncol Rep"},{"key":"1265_CR23","doi-asserted-by":"publisher","unstructured":"Zapata\u2010P\u00e9rez R, et al. NAD+ homeostasis in human health and disease. EMBO Mol Med. 2021;13(7). https:\/\/doi.org\/10.15252\/emmm.202113943.","DOI":"10.15252\/emmm.202113943"},{"issue":"1","key":"1265_CR24","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/j.yexcr.2018.05.007","volume":"369","author":"W Guo","year":"2018","unstructured":"Guo W, et al. The change of nuclear LC3 distribution in acute myeloid leukemia cells. Exp Cell Res. 2018;369(1):69\u201379. https:\/\/doi.org\/10.1016\/j.yexcr.2018.05.007.","journal-title":"Exp Cell Res"},{"issue":"4","key":"1265_CR25","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1007\/s10585-018-9903-0","volume":"35","author":"M Nikolaou","year":"2018","unstructured":"Nikolaou M, et al. The challenge of drug resistance in cancer treatment: a current overview. Clin Exp Metas. 2018;35(4):309\u201318. https:\/\/doi.org\/10.1007\/s10585-018-9903-0.","journal-title":"Clin Exp Metas"},{"issue":"10","key":"1265_CR26","doi-asserted-by":"publisher","first-page":"1161","DOI":"10.1016\/j.ctrv.2014.10.003","volume":"40","author":"S O\u2019Grady","year":"2014","unstructured":"O\u2019Grady S, et al. The role of DNA repair pathways in cisplatin resistant lung cancer. Cancer Treat Rev. 2014;40(10):1161\u201370. https:\/\/doi.org\/10.1016\/j.ctrv.2014.10.003.","journal-title":"Cancer Treat Rev"},{"issue":"6","key":"1265_CR27","doi-asserted-by":"publisher","first-page":"2520","DOI":"10.1096\/fj.201601077R","volume":"31","author":"RP Jablonski","year":"2017","unstructured":"Jablonski RP, et al. SIRT3 deficiency promotes lung fibrosis by augmenting alveolar epithelial cell mitochondrial DNA damage and apoptosis. FASEB J. 2017;31(6):2520\u201332. https:\/\/doi.org\/10.1096\/fj.201601077R.","journal-title":"FASEB J"},{"key":"1265_CR28","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2020\/6782872","volume":"2020","author":"F Jiao","year":"2020","unstructured":"Jiao F, Gong Z. The beneficial roles of SIRT1 in neuroinflammation-related diseases. Oxid Med Cell Longev. 2020;2020:1\u201319. https:\/\/doi.org\/10.1155\/2020\/6782872.","journal-title":"Oxid Med Cell Longev"},{"issue":"3","key":"1265_CR29","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1093\/jmcb\/mjv050","volume":"8","author":"N Ding","year":"2016","unstructured":"Ding N, et al. Mismatch repair proteins recruit DNA methyltransferase 1 to sites of oxidative DNA damage. J Mol Cell Biol. 2016;8(3):244\u201354. https:\/\/doi.org\/10.1093\/jmcb\/mjv050.","journal-title":"J Mol Cell Biol"},{"issue":"7","key":"1265_CR30","doi-asserted-by":"publisher","first-page":"923","DOI":"10.7150\/ijbs.17260","volume":"13","author":"J Zhong","year":"2017","unstructured":"Zhong J, et al. Acetylation of hMOF modulates H4K16ac to regulate DNA repair genes in response to oxidative stress. Int J Biol Sci. 2017;13(7):923\u201334. https:\/\/doi.org\/10.7150\/ijbs.17260.","journal-title":"Int J Biol Sci"},{"key":"1265_CR31","doi-asserted-by":"publisher","first-page":"101195","DOI":"10.1016\/j.molmet.2021.101195","volume":"49","author":"S Amjad","year":"2021","unstructured":"Amjad S, et al. Role of NAD+ in regulating cellular and metabolic signaling pathways. Mol Metab. 2021;49:101195. https:\/\/doi.org\/10.1016\/j.molmet.2021.101195.","journal-title":"Mol Metab"},{"issue":"13","key":"1265_CR32","doi-asserted-by":"publisher","first-page":"3153","DOI":"10.3390\/ijms20133153","volume":"20","author":"DK Alves-Fernandes","year":"2019","unstructured":"Alves-Fernandes DK, Jasiulionis MG. The role of SIRT1 on DNA damage response and epigenetic alterations in cancer. Int J Mol Sci. 2019;20(13):3153. https:\/\/doi.org\/10.3390\/ijms20133153.","journal-title":"Int J Mol Sci"},{"issue":"6","key":"1265_CR33","doi-asserted-by":"publisher","first-page":"2111","DOI":"10.1159\/000493815","volume":"49","author":"W Yu","year":"2018","unstructured":"Yu W, et al. KU70 inhibition impairs both non-homologous end joining and homologous recombination DNA damage repair through SHP-1 induced dephosphorylation of SIRT1 in adult T-Cell leukemia-lymphoma cells. Cell Physiol Biochem. 2018;49(6):2111\u201323. https:\/\/doi.org\/10.1159\/000493815.","journal-title":"Cell Physiol Biochem"},{"issue":"6","key":"1265_CR34","doi-asserted-by":"publisher","first-page":"2935","DOI":"10.3892\/or.2015.4287","volume":"34","author":"L Li","year":"2015","unstructured":"Li L, et al. SIRT1 downregulation enhances chemosensitivity and survival of adult T-cell leukemia-lymphoma cells by reducing DNA double-strand repair. Oncol Rep. 2015;34(6):2935\u201342. https:\/\/doi.org\/10.3892\/or.2015.4287.","journal-title":"Oncol Rep."},{"issue":"1","key":"1265_CR35","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1080\/10428194.2020.1824067","volume":"62","author":"D Zhou","year":"2020","unstructured":"Zhou D, et al. MiR-181a enhances drug sensitivity of mixed lineage leukemia-rearranged acute myeloid leukemia by increasing poly(ADP-ribose) polymerase1 acetylation. Leuk Lymphoma. 2020;62(1):136\u201346. https:\/\/doi.org\/10.1080\/10428194.2020.1824067.","journal-title":"Leuk Lymphoma"},{"key":"1265_CR36","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1016\/j.arr.2018.02.004","volume":"43","author":"ALC Ong","year":"2018","unstructured":"Ong ALC, Ramasamy TS. Role of Sirtuin1-p53 regulatory axis in aging, cancer and cellular reprogramming. Ageing Res Rev. 2018;43:64\u201380. https:\/\/doi.org\/10.1016\/j.arr.2018.02.004.","journal-title":"Ageing Res Rev"},{"key":"1265_CR37","doi-asserted-by":"publisher","unstructured":"Abbasian S, Shokrgozar N, Tamaddon G. Sirtuin1 and chronic myeloid leukemia: a comprehensive glance at drug resistance. Clin Lab. 2021;67(05\/2021). https:\/\/doi.org\/10.7754\/Clin.Lab.2020.200835.","DOI":"10.7754\/Clin.Lab.2020.200835"},{"issue":"6","key":"1265_CR38","first-page":"2711","volume":"12","author":"Y Teng","year":"2020","unstructured":"Teng Y, et al. The Lyn-SIRT1 signaling pathway is involved in imatinib resistance in chronic myeloid leukaemia. Am J Transl Res. 2020;12(6):2711\u201325.","journal-title":"Am J Transl Res."},{"issue":"13","key":"1265_CR39","doi-asserted-by":"publisher","first-page":"3265","DOI":"10.1182\/bloodadvances.2022008585","volume":"7","author":"F Levavasseur","year":"2023","unstructured":"Levavasseur F, et al. FOXP1 regulates oxidative stress, SIRT1 expression, and resistance to chemotherapies in acute myeloid leukemia cells. Blood Adv. 2023;7(13):3265\u201375. https:\/\/doi.org\/10.1182\/bloodadvances.2022008585.","journal-title":"Blood Adv"},{"key":"1265_CR40","doi-asserted-by":"publisher","first-page":"106296","DOI":"10.1016\/j.leukres.2020.106296","volume":"89","author":"K Seipel","year":"2020","unstructured":"Seipel K, et al. MN1, FOXP1 and hsa-miR-181a-5p as prognostic markers in acute myeloid leukemia patients treated with intensive induction chemotherapy and autologous stem cell transplantation. Leuk Res. 2020;89:106296. https:\/\/doi.org\/10.1016\/j.leukres.2020.106296.","journal-title":"Leuk Res"},{"key":"1265_CR41","doi-asserted-by":"publisher","unstructured":"Umemoto T, et al. ATP citrate lyase controls hematopoietic stem cell fate and supports bone marrow regeneration. EMBO J. 2022;41(8). https:\/\/doi.org\/10.15252\/embj.2021109463.","DOI":"10.15252\/embj.2021109463"},{"key":"1265_CR42","doi-asserted-by":"publisher","unstructured":"Zhang T, et al. Heme oxygenase 1 overexpression induces immune evasion of acute myeloid leukemia against natural killer cells by inhibiting CD48. J Trans Med. 2022;20(1). https:\/\/doi.org\/10.1186\/s12967-022-03589-z.","DOI":"10.1186\/s12967-022-03589-z"},{"issue":"9","key":"1265_CR43","doi-asserted-by":"publisher","first-page":"2044","DOI":"10.1002\/ijc.27481","volume":"131","author":"T Kozako","year":"2012","unstructured":"Kozako T, et al. High expression of the longevity gene product SIRT1, and apoptosis induction by sirtinol in adult T-cell leukemia cells. Int J Cancer. 2012;131(9):2044\u201355. https:\/\/doi.org\/10.1002\/ijc.27481.","journal-title":"Int J Cancer."},{"issue":"1","key":"1265_CR44","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1182\/blood-2013-11-538819","volume":"124","author":"D Sasca","year":"2014","unstructured":"Sasca D, et al. SIRT1 prevents genotoxic stress-induced p53 activation in acute myeloid leukemia. Blood. 2014;124(1):121\u201333. https:\/\/doi.org\/10.1182\/blood-2013-11-538819.","journal-title":"Blood"},{"issue":"2","key":"1265_CR45","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1016\/j.yexcr.2018.02.036","volume":"365","author":"W-L Tian","year":"2018","unstructured":"Tian W-L, et al. The IRF9-SIRT1-P53 axis is involved in the growth of human acute myeloid leukemia. Exp Cell Res. 2018;365(2):185\u201393. https:\/\/doi.org\/10.1016\/j.yexcr.2018.02.036.","journal-title":"Exp Cell Res"},{"key":"1265_CR46","doi-asserted-by":"publisher","unstructured":"Niu J, Peng D, Liu L. Drug resistance mechanisms of acute myeloid leukemia stem cells. Front Oncol. 2022;12. https:\/\/doi.org\/10.3389\/fonc.2022.896426.","DOI":"10.3389\/fonc.2022.896426"}],"container-title":["Current Treatment Options in Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11864-024-01265-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11864-024-01265-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11864-024-01265-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,16]],"date-time":"2024-10-16T08:04:26Z","timestamp":1729065866000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11864-024-01265-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10]]},"references-count":46,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2024,10]]}},"alternative-id":["1265"],"URL":"https:\/\/doi.org\/10.1007\/s11864-024-01265-6","relation":{},"ISSN":["1527-2729","1534-6277"],"issn-type":[{"value":"1527-2729","type":"print"},{"value":"1534-6277","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,10]]},"assertion":[{"value":"16 September 2024","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 October 2024","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"This article does not contain any studies with human or animal subjects performed by any of the authors.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Human and Animal Rights and Informed Consent"}}]}}